Rock Creek Pharmaceuticals Inc (fka RCPIQ)

[MineAllMine]

Very interesting. The latest entry is the 2014 Award for Innovative Treatment Evaluation in the amount of $710,843.

It does note that clinical studies have demonstrated the safety and tolerability of anatabine. And it proposes a study of Gulf War vets that would be completed in 2018.

Again, FDA fast track could follow the registration of the GB study and, with the DOD connection, I would think there would be a good chance of getting approval for this study. It's just too bad that a compound so safe has to wait this long to start helping people. And, yes, "helping" people who are shareholders of RCPI too.